Citations

Mayo Clinic

Showing 10 of 108551 citations.

Reverse Dynamization
Glatt, Vaida , Bartnikowski, Nicole , Quirk, Nicholas , Schuetz, Michael , Evans, Christopher H. , Evans, Christopher, Quirk, Nicholas

Journal of Bone and Joint Surgery | April 20, 2016 | Volume: 98 | Issue: 8 | Pages: 677-687

10.2106/jbjs.15.01027 | PMID 27098327 Get It

Background: Reverse dynamization is a technology for enhancing the healing of osseous defects. With use of an external fixator, the axial stiffness across the defect is initially set low and subsequently increased. The purpose of the study described in this paper was to explore the efficacy of reverse dynamization under different conditions. Methods: Rat femoral defects were stabilized with external fixators that allowed the stiffness to be modulated on living animals. Recombinant human bone morphogenetic protein-2 (rhBMP-2) was implanted into the defects on a collagen sponge. Following a dose-response experiment, 5.5 μg of rhBMP-2 was placed into the defect under conditions of very low (25.4-N/mm), low (114-N/mm), medium (185-N/mm), or high (254-N/mm) stiffness. Reverse dynamization was evaluated with 2 different starting stiffnesses: low (114 N/mm) and very low (25.4 N/mm). In both cases, high stiffness (254 N/mm) was imposed after 2 weeks. Healing was assessed with radiographs, micro-computed tomography (μCT), histological analysis, and mechanical testing. Results: In the absence of dynamization, the medium-stiffness fixators provided the best healing. Reverse dynamization starting with very low stiffness was detrimental to healing. However, with low initial stiffness, reverse dynamization considerably improved healing with minimal residual cartilage, enhanced cortication, increased mechanical strength, and smaller callus. Histological analysis suggested that, in all cases, healing provoked by rhBMP-2 occurred by endochondral ossification. Conclusions: These data confirm the potential utility of reverse dynamization as a way of improving bone healing but indicate that the stiffness parameters need to be selected carefully. Clinical Relevance: Reverse dynamization may reduce the amount of rhBMP-2 needed to induce healing of recalcitrant osseous lesions, reduce the time to union, and decrease the need for prolonged external fixation.
Anatomical Findings in Patients Undergoing Total Hip Arthroplasty for Idiopathic Femoral Head Osteonecrosis
Ollivier, Matthieu , Lunebourg, Alexandre , Parratte, Sébastien , Abdel, Matthew P. , Argenson, Jean‐Noël

Journal of Bone and Joint Surgery | April 20, 2016 | Volume: 98 | Issue: 8 | Pages: 672-676

10.2106/jbjs.14.01099 | PMID 27098326 Get It

Background: Osteonecrosis of the femoral head has a host of etiologies. However, in 30% of the cases, no underlying etiology is identified and the process is considered “idiopathic.” Our hypothesis was that osseous anatomical abnormalities might be frequently found in patients with femoral head osteonecrosis. Methods: A retrospective, 1:2 matched, case-control study was undertaken to compare ninety patients with idiopathic osteonecrosis who had undergone lower-limb computed tomography (CT) prior to undergoing total hip arthroplasty with 180 control patients matched for age, sex, and body mass index (BMI) who had undergone lower-limb computed tomography scanning at our radiology department for any reason except articular or bone disease. Preoperative CT scans were performed for all patients to evaluate femoral offset, femoral neck-shaft angle, femoral neck version, femoral head diameter, acetabular coverage estimated with use of the lateral center-edge angle, acetabular version, and acetabular diameter. The mean age was forty-five years, 69% of the patients were men, and the mean BMI was 26 kg/m 2 . Results: Anatomical “abnormalities” associated with osteonecrosis were determined to be a femoral neck-shaft angle of <129° (likelihood ratio [LR] = 3.6), femoral neck version of >17° (LR = 3.8), a lateral center-edge angle of <32° (LR = 5.7), and acetabular version of <19° (LR = 1.38). A combination of three of the four anatomical “abnormalities” was found in 73% of the patients with osteonecrosis but only 11% of the control cases (LR = 6). Conclusions: This 1:2 matched, anatomical study suggests that acetabular and femoral anatomical factors, in isolation or combination, can be found in a large percentage of cases of “idiopathic” osteonecrosis. Clinical Relevance: In this study, isolated or combined abnormalities of the hip were observed in the group of patients with osteonecrosis. Those elements may help surgeons to understand the process underlying idiopathic osteonecrosis and thus require further investigation.
GoldyTALEN Vectors with Improved Efficiency for Golden Gate TALEN Assembly
Welker, Jordan M. , Wierson, Wesley A. , Poshusta, Tanya L., McNulty, Melissa S. , Tisdale, Ellen E., Solin, Staci L., Ekker, Stephen C. , Clark, Karl J. , McGrail, Maura , Essner, Jeffrey J. , Wang, Ying , Ekker, Stephen C , Clark, Karl J , McGrail, Maura , Essner, Jeffrey

Human Gene Therapy | April 19, 2016 | Volume: 27 | Issue: 6 | Pages: 423-424

10.1089/hum.2016.012 | PMID 27094430 Get It

Beta-Poisson model for single-cell RNA-seq data analyses
Vu, Trung Nghia , Wills, Quin F., Kalari, Krishna R. , Niu, Nifang, Wang, Liewei , Rantalainen, Mattias , Pawitan, Yudi , Kalari, Krishna R

Bioinformatics | April 19, 2016 | Volume: 32 | Issue: 14 | Pages: 2128-2135

10.1093/bioinformatics/btw202 | PMID 27153638 Get It

Abstract Motivation: Single-cell RNA-sequencing technology allows detection of gene expression at the single-cell level. One typical feature of the data is a bimodality in the cellular distribution even for highly expressed genes, primarily caused by a proportion of non-expressing cells. The standard and the over-dispersed gamma-Poisson models that are commonly used in bulk-cell RNA-sequencing are not able to capture this property. Results: We introduce a beta-Poisson mixture model that can capture the bimodality of the single-cell gene expression distribution. We further integrate the model into the generalized linear model framework in order to perform differential expression analyses. The whole analytical procedure is called BPSC. The results from several real single-cell RNA-seq datasets indicate that ∼90% of the transcripts are well characterized by the beta-Poisson model; the model-fit from BPSC is better than the fit of the standard gamma-Poisson model in &gt; 80% of the transcripts. Moreover, in differential expression analyses of simulated and real datasets, BPSC performs well against edgeR, a conventional method widely used in bulk-cell RNA-sequencing data, and against scde and MAST, two recent methods specifically designed for single-cell RNA-seq data. Availability and Implementation: An R package BPSC for model fitting and differential expression analyses of single-cell RNA-seq data is available under GPL-3 license at https://github.com/nghiavtr/BPSC . Contact: yudi.pawitan@ki.se or mattias.rantalainen@ki.se Supplementary information: Supplementary data are available at Bioinformatics online.
Founder Mutation Genotyping and Sudden Cardiac Arrest
Kapplinger, Jamie D., Ackerman, Michael J.

Circulation: Cardiovascular Genetics | April 19, 2016 | Volume: 9 | Issue: 2 | Pages: 107-109

10.1161/circgenetics.116.001387 | PMID 27094198 Get It

Pharmacogenetics of Clopidogrel
Pereira, Naveen L. , Geske, Jeffrey B. , Mayr, Manuel , Shah, Svati H. , Rihal, Charanjit S. , Rihal, Charanjit S. , Geske, Jeffrey B

Circulation: Cardiovascular Genetics | April 19, 2016 | Volume: 9 | Issue: 2 | Pages: 185-188

10.1161/circgenetics.115.001318 | PMID 27094200 Get It

Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta‐analysis
Ospina, Naykky Singh , Rodríguez‐Gutiérrez, René , Maraka, Spyridoula , Ycaza, Ana E. Espinosa De, Jasim, Sina , Castaneda‐Guarderas, Ana, Gionfriddo, Michael R. , Nofal, Alaa Al , Brito, Juan P. , Erwin, Patricia J., Richards, Melanie L. , Wermers, Robert A. , Montori, Víctor M. , Ospina, Naykky Singh , Singh Ospina, Naykky M, Espinosa De Ycaza, Ana E, Al Nofal, Alaa, Erwin, Patricia, Richards, Melanie, Wermers, Robert, Al Nofal, Alaa , Maraka, Spyridoula , Montori, Victor M , Singh Ospina, Naykky , Brito, Juan P

World Journal of Surgery | April 19, 2016 | Volume: 40 | Issue: 10 | Pages: 2359-2377

10.1007/s00268-016-3514-1 | PMID 27094563 Get It

AbstractBackgroundParathyroidectomy is a definitive treatment for primary hyperparathyroidism. Patients contemplating this intervention will benefit from knowledge regarding the expected outcomes and potential risks of the currently available surgical options.PurposeTo appraise and summarize the available evidence regarding benefits and harms of minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE).Data sourcesA comprehensive search of multiple databases (MEDLINE, EMBASE, and Scopus) from each database’s inception to September 2014 was performed.Study selectionEligible studies evaluated patients with primary hyperparathyroidism undergoing MIP or BNE.Data extractionReviewers working independently and in duplicate extracted data and assessed the risk of bias.Data synthesisWe identified 82 observational studies and 6 randomized trials at moderate risk of bias. Most of them reported outcomes after MIP (n = 71). Using random‐effects models to pool results across studies, the cure rate was 98 % (95 % CI 97–98 %, I2 = 10 %) with BNE and 97 % (95 % CI 96–98 %, I2 = 86 %) with MIP. Hypocalcemia occurred in 14 % (95 % CI 10–17 % I2 = 93 %) of the BNE cases and in 2.3 % (95 % CI 1.6–3.1 %, I2 = 87 %) with MIP (P < 0.001). There was a statistically significant lower risk of laryngeal nerve injury with MIP (0.3 %) than with BNE (0.9 %), but similar risk of infection (0.5 vs. 0.5 %) and mortality (0.1 vs. 0.5 %).LimitationsThe available evidence, mostly observational, is at moderate risk of bias, and limited by indirect comparisons and inconsistency for some outcomes (cure rate, hypocalcemia).ConclusionMIP and BNE are both effective surgical techniques for the treatment of primary hyperparathyroidism. The safety profile of MIP appears superior to BNE (lower rate of hypocalcemia and recurrent laryngeal nerve injury).
Whole Exome Sequencing Leading to the Diagnosis of Dysferlinopathy with a Novel Missense Mutation (c.959G>C)
Swaika, Abhisek, Boczek, Nicole J. , Sood, Neha, Guthrie, Kimberly J., Klee, Eric W. , Dimberg, Elliot L., Guthrie, Kimberly, Agrawal, Ankit, Agrawal, Ankit Kumar , Ailawadhi, Sikander

Case Reports in Genetics | April 19, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-4

10.1155/2016/9280812 | PMID 27195159 Get It

Dysferlinopathy is an uncommon, progressive muscular dystrophy that has a wide phenotypic variability and primarily supportive management (Nguyen et al., 2007; Narayanaswami et al., 2014). Amyloid myopathy is a distinct, rare disorder that can present similarly to inflammatory myopathies and requires a high clinical suspicion for early intervention to prolong survival. Amyloid myopathy is typically associated with other systemic manifestations of amyloidosis, but rare cases of isolated amyloid myopathy have been described (Mandl et al., 2000; Hull et al., 2001). Positive Congo red stains on tissue biopsy remain the gold standard for diagnosis (Spuler et al., 1998; Karacostas et al., 2005). A high clinical suspicion and meticulous diagnostic workup that includes novel techniques are necessary for identifying these rare disorders. We report a middle-aged man with progressive leg muscle weakness who was initially treated as having amyloid myopathy but was later diagnosed as having dysferlinopathy by Whole Exome Sequencing (WES) analysis. We also report a novel missense mutation (c.959G>C) to help correlate in any patient with presumed dysferlinopathy and to add to the already known genotype of this disorder.
Which Malpositioned Pedicle Screws Should Be Revised?
Floccari, Lorena V. , Larson, A. Noelle , Crawford, Charles H. , Ledonio, Charles Gerald T., Polly, David W. , Carreon, Leah Y. , Blakemore, Laurel C. , Larson, A Noelle , Polly, David

Journal of Pediatric Orthopaedics | April 19, 2016 | Volume: 38 | Issue: 2 | Pages: 110-115

10.1097/bpo.0000000000000753 | PMID 27078232 Get It

Background: Up to 10% of free-hand pedicle screws are malpositioned, and 1 in 300 patients may undergo return to surgery for revision of malpositioned screws. The indications for revision of asymptomatic malpositioned screws have not been carefully examined in the literature. We sought to evaluate the threshold among spinal deformity surgeons for revision of malpositioned screws. Methods: Twelve experienced spine surgeons reviewed x-ray and computed tomographic images of 32 malpositioned pedicle screws with variable degrees of anterior, medial, and lateral breeches. The surgeons were asked whether based on the image they would revise the screw: (1) intraoperatively before rod placement; (2) intraoperatively after rod placement; (3) in clinic with an asymptomatic patient. For each scenario, we assumed stable neuromonitoring and no neurological changes. Agreement and multirater κ was calculated. Results: There was good agreement as to which screws were malpositioned (80% agreement, κ=0.703). After the rod was placed or postoperatively (scenarios 2 and 3), surgeons less frequently recommended screw revision, and there was greater variability among the surgeons’ recommendations. For return to surgery from clinic for asymptomatic screw revision, % agreement was only 65% (κ=0.477). The majority recommended revision surgery for screws which approached the dura (10/12) or the aorta (7/12 surgeons). Half of the surgeons recommended revision surgery for an asymptomatic screw if the entire screw diameter was in the canal. Revision surgery was not recommended for asymptomatic patients with screws partially violating the canal (<½ the screw diameter), malpositioned laterally in the rib head, or with small anterior cortical violations remote from a vascular structure. Conclusions: There is significant variability of opinion among surgeons regarding which malpositioned screws can be safely observed in an asymptomatic patient. Given the frequency of malpositioned screws and morbidity of surgical return to surgery, more long-term data are needed to develop practice guidelines for determining which screws require revision surgery. Level of Evidence: Level III—retrospective comparative study.
FLATTENING OF A TREATMENT-RESISTANT RETINAL PIGMENT EPITHELIAL DETACHMENT AFTER A SINGLE INTRAVITREAL INJECTION OF ZIV-AFLIBERCEPT
Yogi, Rohit, Stewart, Michael, Chhablani, Jay

RETINAL Cases & Brief Reports | April 19, 2016 | Volume: 11 | Issue: 2 | Pages: 111-113

10.1097/icb.0000000000000305 | PMID 27078613 Get It

Purpose: To report flattening of a treatment-resistant retinal pigment epithelial detachment (PED) due to neovascular age-related macular degeneration after a single intravitreal injection of ziv-aflibercept (Zaltrap). Methods: A 67-year-old woman with a neovascular age-related macular degeneration–related PED was treated with intravitreal injections of bevacizumab and ranibizumab, and in combination with verteporfin photodynamic therapy, before receiving a single intravitreal injection of ziv-aflibercept (1.25 mg/0.05 mL). Results: The patient presented with a visual acuity of 20/30 in the right eye, a PED height of 581 μm, and a central macular thickness of 381 μm. She received eight intravitreal injections of bevacizumab and ranibizumab, one in combination with photodynamic therapy. The height of the PED and the central macular thickness varied over time, but 3 years later, they measured 382 μm and 418 μm, respectively. A single intravitreal injection of ziv-aflibercept resulted in a dramatic reduction in PED height to 140 μm, which was maintained 2 months later. The visual acuity remained stable, and there were no clinical signs of toxicity. Conclusion: Intravitreal ziv-aflibercept safely and effectively improved a treatment-resistant PED. Intravitreal ziv-aflibercept could become a treatment option for neovascular age-related macular degeneration in countries where aflibercept (Eylea) is not available or its cost is prohibitive, but further studies are necessary to establish efficacy and safety.